(Q46150004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Maria Gabriella Ferrandina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

8

Giovanni Scambia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

Enrica Martinelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

9

Cristiano Ferlini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

Salvatore Santaguida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

7

Gianfranco Zannoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Marco Petrillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Maria Grazia Prisco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Adriana Zucconi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

20 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

237-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Relapsed ovarian cancer: challenges and management strategies for a chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Invasive growth: a MET-driven genetic programme for cancer and stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

RON, a tyrosine kinase receptor involved in tumor progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Overexpression of the Met/HGF receptor in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.013

10.1016/J.YGYNO.2008.07.013

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18718649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference